Upstream Bio, Inc. (UPB)
1.59
-0.41
(-20.50%)
USD |
NASDAQ |
Nov 20, 16:00
1.62
+0.03
(+1.89%)
After-Hours: 20:00
Upstream Bio Net Income (Quarterly) : -41.19M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -41.19M |
| June 30, 2026 | -39.70M |
| March 31, 2026 | -40.59M |
| December 31, 2025 | -42.46M |
| September 30, 2025 | -33.75M |
| Date | Value |
|---|---|
| June 30, 2025 | -39.97M |
| March 31, 2025 | -27.27M |
| December 31, 2024 | -21.24M |
| September 30, 2024 | -15.99M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 53.52M |
| Alnylam Pharmaceuticals, Inc. | 2.167B |
| Anika Therapeutics, Inc. | -0.311M |
| Savara, Inc. | -42.99M |
| Arrowhead Pharmaceuticals, Inc. | -428.88M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.395M |
| Total Expenses (Quarterly) | 41.59M |
| EPS Diluted (Quarterly) | -0.7519 |
| Enterprise Value | -119.43M |
| Gross Profit Margin (Quarterly) | 87.59% |
| Profit Margin (Quarterly) | -10.43K% |
| Earnings Yield | -189.5% |
| Normalized Earnings Yield | -189.27 |